Cambridge VC firm Flagship targets $500M for latest fund

Flagship Pioneering could soon overtake Third Rock Ventures as the state ’s largest venture capital firm focused on life sciences investments. According to an SEC filing on Thursday, Cambridge-based Flagship is targeting $500 million for a new fund. It would be the firm’s seventh since it was founded in 1999, and bring its total under management from $1.75 billion c urrently to $2.25 billion. By comparison, Third Rock, which is based in Boston, has raised a total of $1.9 billion in its 10-year…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news